Marktanalyse - Emergency Contraception in Latvia

Emergency contraception witnessed sales growth in 2011. The government was not successful in improving the birth rate, which could have affected development of emergency contraception in 2011. The birth rate remained stable and total population was decreasing in Latvia, which explained growth of emergency contraception.

Euromonitor International's Emergency Contraception in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

EMERGENCY CONTRACEPTION IN LATVIA

Euromonitor International

May 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Emergency Contraception: Value 2006-2011

Table 2 Sales of Emergency Contraception: % Value Growth 2006-2011

Table 3 Emergency Contraception Company Shares 2007-2011

Table 4 Emergency Contraception Brand Shares 2008-2011

Table 5 Forecast Sales of Emergency Contraception: Value 2011-2016

Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Executive Summary

Recovery Brings Optimism

Improved Economic Situation Benefits Value Sales

More Intense Competition, But With Different Effects on Consumer Health

Regulation Limits Changes in Distribution

Positive Growth Expected With Few Threats To Growth

Key Trends and Developments

Economic Factors As Major Driving Force

International Brands Lead the Sales

Herbal/traditional Products Grow Faster

Less Regulation Benefits Vitamins and Dietary Supplements

Private Label Has Potential for Growth

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Penetration of Private Label by Category 2006-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

Summary 1 OTC Healthcare Switches 2009-2011

Definitions

Sources

Summary 2 Research Sources

• Emergency Contraception in Azerbaijan
• Emergency Contraception in China
• Emergency Contraception in Australia
• Emergency Contraception in Uruguay
• Emergency Contraception in Kenya
• Emergency Contraception in Portugal
• Emergency Contraception in the Netherlands
• Emergency Contraception in Austria
• Emergency Contraception in Nigeria
• Emergency Contraception in Serbia
• HIV-Associated Lipodystrophy Syndrome – Pipeline Review, H2 2012
• Emergency Contraception in Belgium
• Emergency Contraception in India
• Emergency Contraception in India
• Emergency Contraception in Ireland
• Emergency Contraception in Norway
• Emergency Contraception in Sweden
• Emergency Contraception in Switzerland
• Emergency Contraception in the United Kingdom
• Emergency Contraception in Finland